Ocean Financial Statements From 2010 to 2024

OCEA Stock   1.46  0.01  0.68%   
Ocean Biomedical financial statements provide useful quarterly and yearly information to potential Ocean Biomedical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ocean Biomedical financial statements helps investors assess Ocean Biomedical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ocean Biomedical's valuation are summarized below:
Market Capitalization
50.9 M
Earnings Share
(3.00)
We have found seventy-five available trending fundamental ratios for Ocean Biomedical, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Ocean Biomedical recent market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.
Check Ocean Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ocean main balance sheet or income statement drivers, such as Selling General Administrative of 34.3 M, Total Revenue of 0.0 or Other Operating Expenses of 2.7 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.25. Ocean financial statements analysis is a perfect complement when working with Ocean Biomedical Valuation or Volatility modules.
  
This module can also supplement various Ocean Biomedical Technical models . Check out the analysis of Ocean Biomedical Correlation against competitors.
For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.

Ocean Biomedical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Other Current Liabilities1.1 M1.1 M949.9 K
Slightly volatile
Total Current Liabilities3.5 MM1.5 M
Slightly volatile
Accounts Payable232.9 K373.6 K236.1 K
Pretty Stable
Common Stock Shares Outstanding13.4 M11.9 M18.3 M
Slightly volatile
Non Current Liabilities Total3.8 M3.6 M1.1 M
Slightly volatile
Total Liabilities4.4 M7.6 MM
Slightly volatile
Liabilities And Stockholders Equity133.9 M127.5 M25.1 M
Slightly volatile
Other Current Assets76.7 K80.7 K331.2 K
Slightly volatile
Non Currrent Assets Other119.7 M127 M109.5 M
Slightly volatile
Cash And Short Term Investments213.6 K377.6 K109.3 K
Slightly volatile
Common Stock119.6 M127 M109.5 M
Slightly volatile
Short and Long Term Debt Total1.7 M1.9 M2.1 M
Slightly volatile
Net Receivables40 K45 K49 K
Slightly volatile
Short and Long Term Debt1.7 M1.9 M2.1 M
Slightly volatile
Short Term Debt1.7 M1.9 M2.1 M
Slightly volatile

Ocean Biomedical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative34.3 M32.7 M8.5 M
Slightly volatile
Other Operating Expenses2.7 M2.9 MM
Slightly volatile
Research Development41 M39 M9.9 M
Slightly volatile
Total Operating Expenses2.7 M2.9 MM
Slightly volatile
Interest Expense676622933
Slightly volatile
Net Interest Income1.2 M1.4 M1.5 M
Slightly volatile
Interest Income1.2 M1.4 M1.5 M
Slightly volatile

Ocean Biomedical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change In Working Capital2.3 MM977.5 K
Slightly volatile
Other Cashflows From Financing Activities5.1 M4.8 M993.4 K
Slightly volatile
Change To Operating Activities5.7 M5.5 M1.6 M
Slightly volatile
Total Cash From Financing Activities2.5 M2.4 M591.2 K
Slightly volatile
Change To Netincome45.2 M50.9 M55.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Invested Capital0.01650.01860.0202
Slightly volatile
Average Payables224.7 K252.8 K275.3 K
Slightly volatile
ROIC0.0150.01581.2695
Pretty Stable
Cash Per Share0.01180.02230.0076
Slightly volatile
Income Quality0.740.70.1775
Slightly volatile
ROE0.00590.00621.2681
Pretty Stable
Current Ratio0.120.160.1531
Slightly volatile
Graham Number2.12.481.0402
Slightly volatile
Debt To Equity0.01650.01860.0202
Slightly volatile
Interest Debt Per Share0.130.150.1596
Slightly volatile
Debt To Assets0.01550.01740.019
Slightly volatile
Ebt Per Ebit0.880.440.9142
Slightly volatile
Effective Tax Rate1.271.431.558
Slightly volatile
Total Debt To Capitalization0.01620.01820.0198
Slightly volatile
Debt Equity Ratio0.01650.01860.0202
Slightly volatile
Quick Ratio0.10.09830.0276
Slightly volatile
Cash Ratio0.08960.08530.0251
Slightly volatile
Debt Ratio0.01550.01740.019
Slightly volatile
Return On Equity0.00590.00621.2681
Pretty Stable

Ocean Biomedical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap161.1 M181.3 M197.4 M
Slightly volatile
Enterprise Value161.1 M181.3 M197.4 M
Slightly volatile

Ocean Fundamental Market Drivers

Cash And Short Term Investments328.3 K

About Ocean Biomedical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Ocean Biomedical income statement, its balance sheet, and the statement of cash flows. Ocean Biomedical investors use historical funamental indicators, such as Ocean Biomedical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ocean Biomedical investors may use each financial statement separately, they are all related. The changes in Ocean Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ocean Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Ocean Biomedical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Ocean Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue 0.00  0.00 
Stock Based Compensation To Revenue 0.00  0.00 
Sales General And Administrative To Revenue 0.00  0.00 
Research And Ddevelopement To Revenue 0.00  0.00 
Capex To Revenue 0.00  0.00 
Revenue Per Share 0.00  0.00 
Ebit Per Revenue 0.00  0.00 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ocean Biomedical is a strong investment it is important to analyze Ocean Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocean Biomedical's future performance. For an informed investment choice regarding Ocean Stock, refer to the following important reports:
Check out the analysis of Ocean Biomedical Correlation against competitors.
For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.
Note that the Ocean Biomedical information on this page should be used as a complementary analysis to other Ocean Biomedical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Ocean Stock analysis

When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Correlations
Find global opportunities by holding instruments from different markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Is Ocean Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.00)
Return On Assets
(6.82)
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.